SCHEMBL845401

SCHEMBL845401

CC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3cccnc3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
HRH3 Q9Y5N1 1/20 0.43
FKBP1A P62942 1/20 0.43
ACE P12821 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
PAX8 Q06710 1/20 0.41
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
ATM Q13315 1/20 0.41
ITGB1 P05556 1/20 0.41
ITGA4 P13612 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
VNN1 O95497 1/20 0.41
MAPK10 P53779 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845191 0.92 HRH3 (0.52) ALDH1A1HRH3FKBP1AACETRPV1
SCHEMBL845534 0.91 HRH3 (0.43) ALDH1A1HRH3FKBP1AACETRPV1
SCHEMBL845712 0.89 HRH3 (0.50) ALDH1A1HRH3ACEKDM4ELMNA
SCHEMBL844923 0.89 ALDH1A1 (0.43) ALDH1A1TRPV1KDM4ELMNAHCRTR1
SCHEMBL845408 0.89 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAHCRTR1HCRTR2
SCHEMBL845154 0.89 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAHCRTR1HCRTR2
SCHEMBL845015 0.87 ALDH1A1 (0.42) ALDH1A1HRH3FKBP1AACEKDM4E
SCHEMBL12488545 0.86 ALDH1A1 (0.42) ALDH1A1HRH3FKBP1AACETRPV1
SCHEMBL2179845 0.86 ALDH1A1 (0.42) ALDH1A1HRH3FKBP1AACETRPV1
SCHEMBL845375 0.85 MAPK1 (0.46) ALDH1A1KDM4EATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed